Tyra Biosciences, Inc.TYRANASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

7 analysts·Limited coverage

100%

Rating Distribution

Strong Buy

00%

Buy

7100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 40% higher.

Bear Case

$36.00

+16%

Consensus

$43.50

+40%

Bull Case

$59.00

+90%

Price Range7 analysts

Low

Consensus

High

$36.00

$59.00

Current Target

Current Price

$31.02

Upside to Target

$12.48

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-2.22(7 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+130.81%

EPS—

FY2028

Rev+1516.38%

EPS—

FY2029

Rev+238.21%

EPS—

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+5.3%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 27, 2026Barclays

Tyra Biosciences initiated with an Overweight at Barclays

Target:$59.00

+87.9%from $31.40

Jan 23, 2026Piper Sandler

Tyra Biosciences price target raised to $42 from $33 at Piper Sandler

Target:$42.00

+35.9%from $30.91

Dec 16, 2025Wedbush

Wedbush raises price target on Tyra Biosciences, adds to Best Ideas List

Target:$37.00

+67.3%from $22.11

Sep 10, 2025Oppenheimer

Tyra Biosciences price target raised to $36 from $30 at Oppenheimer

Target:$36.00

+195.5%from $12.18

Nov 11, 2024H.C. Wainwright

Tyra Biosciences (TYRA) PT Lowered to $30 at H.C. Wainwright

Target:$30.00

+79.6%from $16.70

Oct 18, 2024Bank of America Securities

BofA Securities Upgrades Tyra Biosciences (TYRA) to Buy

Target:$31.00

+19.3%from $25.98

Sep 19, 2024Oppenheimer

Tyra Biosciences (TYRA) PT Raised to $33 at Oppenheimer

Target:$33.00

+33.9%from $24.64

Aug 15, 2024Raymond James

Piper Sandler Starts Tyra Biosciences (TYRA) at Overweight

Target:$33.00

+53.0%from $21.57

Aug 8, 2024H.C. Wainwright

Tyra Biosciences (TYRA) PT Raised to $25 at H.C. Wainwright

Target:$25.00

+28.2%from $19.50

Mar 20, 2024H.C. Wainwright

Tyra Biosciences (TYRA) PT Raised to $23 at H.C. Wainwright on potential upside from TYRA-300

Target:$23.00

+32.4%from $17.37

Feb 3, 2023Oppenheimer

Oppenheimer Initiates Coverage On Tyra Biosciences with Outperform Rating, Announces Price Target of $17

Target:$17.00

+27.8%from $13.30

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance